- Home
- Publications
- Publication Search
- Publication Details
Title
Gaucher Disease and Bone Manifestations
Authors
Keywords
Gaucher disease, Bone, Biomarkers, Enzyme replacement therapy, Substrate reduction therapy, Osteonecrosis
Journal
CALCIFIED TISSUE INTERNATIONAL
Volume 95, Issue 6, Pages 477-494
Publisher
Springer Nature
Online
2014-11-15
DOI
10.1007/s00223-014-9923-y
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Eliglustat, an investigational oral therapy for Gaucher disease type 1: Phase 2 trial results after 4years of treatment
- (2014) Elena Lukina et al. BLOOD CELLS MOLECULES AND DISEASES
- Impact of velaglucerase alfa on bone marrow burden score in adult patients with type 1 Gaucher disease: 7-Year follow-up
- (2014) Deborah Elstein et al. BLOOD CELLS MOLECULES AND DISEASES
- Skeletal improvement in patients with Gaucher disease type 1: a phase 2 trial of oral eliglustat
- (2014) Ravi S. Kamath et al. SKELETAL RADIOLOGY
- Histologic Findings of Femoral Heads From Patients With Gaucher Disease Treated With Enzyme Replacement
- (2013) Ehud Lebel et al. AMERICAN JOURNAL OF CLINICAL PATHOLOGY
- Malignancies and monoclonal gammopathy in Gaucher disease; a systematic review of the literature
- (2013) Maarten Arends et al. BRITISH JOURNAL OF HAEMATOLOGY
- Glucosylsphingosine Is a Highly Sensitive and Specific Biomarker for Primary Diagnostic and Follow-Up Monitoring in Gaucher Disease in a Non-Jewish, Caucasian Cohort of Gaucher Disease Patients
- (2013) Arndt Rolfs et al. PLoS One
- Velaglucerase alfa enzyme replacement therapy compared with imiglucerase in patients with Gaucher disease
- (2012) Hadhami Ben Turkia et al. AMERICAN JOURNAL OF HEMATOLOGY
- Cathepsin-mediated regulation of autophagy in saposin C deficiency
- (2012) Massimo Tatti et al. Autophagy
- Taliglucerase alfa leads to favorable bone marrow responses in patients with type I Gaucher disease
- (2012) L. van Dussen et al. BLOOD CELLS MOLECULES AND DISEASES
- Osteoclasts Have Multiple Roles in Bone in Addition to Bone Resorption
- (2012) Brendan Boyce et al. CRITICAL REVIEWS IN EUKARYOTIC GENE EXPRESSION
- How I treat Gaucher disease
- (2011) A. Zimran BLOOD
- Booster-effect with velaglucerase alfa in patients with Gaucher disease switched from long-term imiglucerase therapy: Early Access Program results from Jerusalem
- (2011) Deborah Elstein et al. BLOOD CELLS MOLECULES AND DISEASES
- Bone remodelling at a glance
- (2011) J. C. Crockett et al. JOURNAL OF CELL SCIENCE
- Markers of Bone Turnover in Gaucher Disease: Modeling the Evolution of Bone Disease
- (2011) L. van Dussen et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Osseous Manifestations of Adult Gaucher Disease in the Era of Enzyme Replacement Therapy
- (2011) Patrick B. Deegan et al. MEDICINE
- Therapeutic approaches to bone pathology in Gaucher disease: Past, present and future
- (2011) Ozlem Goker-Alpan MOLECULAR GENETICS AND METABOLISM
- A reappraisal of Gaucher disease-diagnosis and disease management algorithms
- (2010) Pramod K. Mistry et al. AMERICAN JOURNAL OF HEMATOLOGY
- Hyperferritinemia and iron overload in type 1 Gaucher disease
- (2010) Philip Stein et al. AMERICAN JOURNAL OF HEMATOLOGY
- Improvement in hematological, visceral, and skeletal manifestations of Gaucher disease type 1 with oral eliglustat tartrate (Genz-112638) treatment: 2-year results of a phase 2 study
- (2010) E. Lukina et al. BLOOD
- Early achievement and maintenance of the therapeutic goals using velaglucerase alfa in type 1 Gaucher disease
- (2010) D. Elstein et al. BLOOD CELLS MOLECULES AND DISEASES
- Hip arthroplasty in patients with Gaucher disease
- (2010) Ehud Lebel et al. BLOOD CELLS MOLECULES AND DISEASES
- Glucocerebrosidase gene-deficient mouse recapitulates Gaucher disease displaying cellular and molecular dysregulation beyond the macrophage
- (2010) P. K. Mistry et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The underrecognized progressive nature of N370S Gaucher disease and assessment of cancer risk in 403 patients
- (2009) Tamar H. Taddei et al. AMERICAN JOURNAL OF HEMATOLOGY
- The Erlenmeyer flask bone deformity in the skeletal dysplasias
- (2009) Maha A. Faden et al. AMERICAN JOURNAL OF MEDICAL GENETICS PART A
- The female Gaucher patient: The impact of enzyme replacement therapy around key reproductive events (menstruation, pregnancy and menopause)
- (2009) Ari Zimran et al. BLOOD CELLS MOLECULES AND DISEASES
- Improvement of bone disease by imiglucerase (Cerezyme) therapy in patients with skeletal manifestations of type 1 Gaucher disease: results of a 48-month longitudinal cohort study
- (2009) KB Sims et al. CLINICAL GENETICS
- Treating lysosomal storage diseases with pharmacological chaperones: from concept to clinics
- (2009) Giancarlo Parenti EMBO Molecular Medicine
- Dose-response relationships for enzyme replacement therapy with imiglucerase/alglucerase in patients with Gaucher disease type 1
- (2009) Gregory A Grabowski et al. GENETICS IN MEDICINE
- Real-world clinical experience with long-term miglustat maintenance therapy in type 1 Gaucher disease: the ZAGAL project
- (2009) P. Giraldo et al. HAEMATOLOGICA
- Glucocerebroside: an evolutionary advantage for patients with Gaucher disease and a new immunomodulatory agent
- (2009) Yaron Ilan et al. IMMUNOLOGY AND CELL BIOLOGY
- Identification and Characterization of Ambroxol as an Enzyme Enhancement Agent for Gaucher Disease
- (2009) Gustavo H. B. Maegawa et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Miglustat (Zavesca®) in type 1 Gaucher disease: 5-year results of a post-authorisation safety surveillance programme
- (2009) Carla E. M. Hollak et al. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
- A benchmark analysis of the achievement of therapeutic goals for type 1 Gaucher disease patients treated with imiglucerase
- (2008) Neal Weinreb et al. AMERICAN JOURNAL OF HEMATOLOGY
- Randomized, controlled trial of miglustat in Gaucher's disease type 3
- (2008) Raphael Schiffmann et al. ANNALS OF NEUROLOGY
- Changes of Bone Metabolism in Seven Patients with Gaucher Disease Treated Consecutively with Imiglucerase and Miglustat
- (2008) P. Mikosch et al. CALCIFIED TISSUE INTERNATIONAL
- Persistent bone disease in adult type 1 Gaucher disease despite increasing doses of enzyme replacement therapy
- (2008) M. de Fost et al. HAEMATOLOGICA
- Gaucher disease: mutation and polymorphism spectrum in the glucocerebrosidase gene (GBA)
- (2008) Kathleen S. Hruska et al. HUMAN MUTATION
- Phenotypic heterogeneity of N370S homozygotes with type I Gaucher disease: An analysis of 798 patients from the ICGG Gaucher Registry
- (2008) C. Fairley et al. JOURNAL OF INHERITED METABOLIC DISEASE
- ‘Non-neuronopathic’ Gaucher disease reconsidered. Prevalence of neurological manifestations in a Dutch cohort of type I Gaucher disease patients and a systematic review of the literature
- (2008) M. Biegstraaten et al. JOURNAL OF INHERITED METABOLIC DISEASE
- Eight-Year Clinical Outcomes of Long-Term Enzyme Replacement Therapy for 884 Children With Gaucher Disease Type 1
- (2008) H. Andersson et al. PEDIATRICS
- Molecular aspects of osteopathy in type 1 Gaucher disease: correlation between genetics and bone density
- (2008) Efrat Arnheim et al. RHEUMATOLOGY INTERNATIONAL
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now